Nonalcoholinesteatohepatitis with Liver Fibrosis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-03-21
Clinical Trial Update: Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) [Phase 2]
Pfizer completed a Phase 2 trial (MIRNA) evaluating metabolic interventions for nonalcoholic steatohepatitis with liver fibrosis. Results ha…